Copy-number variation in control population cohorts


1 The Centre for Applied Genomics and 2 Program in Genetics and Genomic Biology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
* To whom correspondence should be addressed at: The Centre for Applied Genomics, The Hospital for Sick Children, 14th Floor, Toronto Medical Discovery Tower/MaRS Discovery District, 101 College Street, Room 14-701, Ontario, Canada, M5G 1L7. Tel: +1 4168137613; Fax: +1 4168138319; Email: steve{at}genet.sickkids.on.ca
Received August 2, 2007; Revised August 2, 2007; Accepted August 22, 2007
Copy-number variation (CNV) is the most prevalent type of structural variation in the human genome, and contributes significantly to genetic heterogeneity. It has already been recognized that some CNVs can contribute to human phenotype, including rare genomic disorders and Mendelian diseases. Other CNVs are now amenable to genome-wide association studies so that their influence on human phenotypic diversity and disease susceptibility may soon be more readily determined. Population studies and reference databases for control and disease-associated samples are required to provide an information resource about CNV frequencies and their relative contribution to phenotypic outcomes. The relatively high cost of screening individual samples has tended to limit the number of controls assayed, and use of the data has often been hampered by the variety of technology platforms and analysis techniques. As a result, there is still a paucity of data on population frequency and distribution of CNVs, particularly for those that are rare. Here, we provide an example of how to discover new CNVs from existing genotype data from large-scale genetic epidemiological studies. We also discuss the need to expand surveys of CNV in different population-based cohorts and to apply the information to studies of human variation and disease.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Cusco, A. Medrano, B. Gener, M. Vilardell, F. Gallastegui, O. Villa, E. Gonzalez, B. Rodriguez-Santiago, E. Vilella, M. Del Campo, et al. Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder Hum. Mol. Genet., May 15, 2009; 18(10): 1795 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
D T Miller, Y Shen, L A Weiss, J Korn, I Anselm, C Bridgemohan, G F Cox, H Dickinson, J Gentile, D J Harris, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders J. Med. Genet., April 1, 2009; 46(4): 242 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, J. Sun, G. Li, Y. Zhu, S. Zhang, S.-T. Kim, J. Sun, F. Wiklund, K. Wiley, S. D. Isaacs, et al. Association of a Germ-Line Copy Number Variation at 2p24.3 and Risk for Aggressive Prostate Cancer Cancer Res., March 15, 2009; 69(6): 2176 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rujescu, A. Ingason, S. Cichon, O. P.H. Pietilainen, M. R. Barnes, T. Toulopoulou, M. Picchioni, E. Vassos, U. Ettinger, E. Bramon, et al. Disruption of the neurexin 1 gene is associated with schizophrenia Hum. Mol. Genet., March 1, 2009; 18(5): 988 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gusev, J. K. Lowe, M. Stoffel, M. J. Daly, D. Altshuler, J. L. Breslow, J. M. Friedman, and I. Pe'er Whole population, genome-wide mapping of hidden relatedness Genome Res., February 1, 2009; 19(2): 318 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jasmine, H. Ahsan, I. L. Andrulis, E. M. John, J. Chang-Claude, and M. G. Kibriya Whole-Genome Amplification Enables Accurate Genotyping for Microarray-Based High-Density Single Nucleotide Polymorphism Array Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3499 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. K. Chiang, A. Derti, D. Schwartz, M. F. Chou, J. N. Hirschhorn, and C.-t. Wu Ultraconserved Elements: Analyses of Dosage Sensitivity, Motifs and Boundaries Genetics, December 1, 2008; 180(4): 2277 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shlien, U. Tabori, C. R. Marshall, M. Pienkowska, L. Feuk, A. Novokmet, S. Nanda, H. Druker, S. W. Scherer, and D. Malkin Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome PNAS, August 12, 2008; 105(32): 11264 - 11269. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Kuniba, M Tsuda, M Nakashima, S Miura, N Miyake, T Kondoh, T Matsumoto, H Moriuchi, H Ohashi, K Kurosawa, et al. Lack of C20orf133 and FLRT3 mutations in 43 patients with Kabuki syndrome in Japan J. Med. Genet., July 1, 2008; 45(7): 479 - 480. [Full Text] [PDF] |
||||






